CEO Lee Frank D. bought 8,264 shares of PCRX at $12.10; stock down -67.4% from 52-week high amid cluster buy pattern
Lee Frank D., Chief Executive Officer of Pacira BioSciences, purchased 8,264 shares at $12.10 on 2024-08-12, increasing his holdings from 99,520 to 107,784 shares. This transaction occurs within a cluster pattern: 2 other insiders also bought within the past 14 days, suggesting coordinated confidence at depressed valuations. The stock is trading at $12.40 currently, down -67.4% from its 52-week high of $38.06 and down -58.8% over the past 90 days, yet the company maintains solid fundamentals with Revenue $178,023,000.00 and Net income $18,886,000.00, trading at a P/E of 8.99. The convergence of executive capital commitment alongside peer insider purchases during a sharp equity drawdown warrants investor attention to what prompted this accumulation pattern and whether it reflects conviction in recovery prospects or response to near-term operational concerns.